sulfasalazine has been researched along with Bile Duct Cancer in 2 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| STAUFFER, MH | 1 |
| SAUER, WG | 1 |
| DEARING, WH | 1 |
| BAGGENSTOSS, AH | 1 |
| Gillies, M | 1 |
| Skyring, A | 1 |
2 other studies available for sulfasalazine and Bile Duct Cancer
| Article | Year |
|---|---|
THE SPECTRUM OF CHOLESTATIC HEPATIC DISEASE.
Topics: Adolescent; Alkaline Phosphatase; Aspartate Aminotransferases; Bile Duct Neoplasms; Bilirubin; Blood | 1965 |
Ulcerative colitis: the experience of a Sydney teaching hospital.
Topics: Acute Disease; Adolescent; Adult; Australia; Bile Duct Neoplasms; Carcinoma; Child; Child, Preschool | 1970 |